Skip to content
You are now leaving https://www.ionispharma.com to visit

Akcea Therapeutics Announces Pricing of Initial Public Offering

CAMBRIDGE, Mass. , July 13, 2017 /PRNewswire/ — Akcea Therapeutics, Inc. today announced the pricing of its initial public offering of 15,625,000 shares common stock at a public offering price of $8.00 per share, for gross proceeds of $125.0 million before underwriting discounts and commissions